Please use this identifier to cite or link to this item: https://doi.org/10.1128/CVI.00452-15
DC FieldValue
dc.titleContrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth Cohort
dc.contributor.authorDent, A.E
dc.contributor.authorMalhotra, I
dc.contributor.authorWang, X
dc.contributor.authorBabineau, D
dc.contributor.authorYeo, K.T
dc.contributor.authorAnderson, T
dc.contributor.authorKimmel, R.J
dc.contributor.authorAngov, E
dc.contributor.authorLanar, D.E
dc.contributor.authorNarum, D
dc.contributor.authorDutta, S
dc.contributor.authorRichards, J
dc.contributor.authorBeeson, J.G
dc.contributor.authorCrabb, B.S
dc.contributor.authorCowman, A.F
dc.contributor.authorHorii, T
dc.contributor.authorMuchiri, E
dc.contributor.authorMungai, P.L
dc.contributor.authorKing, C.L
dc.contributor.authorKazura, J.W
dc.date.accessioned2020-10-27T10:47:13Z
dc.date.available2020-10-27T10:47:13Z
dc.date.issued2016
dc.identifier.citationDent, A.E, Malhotra, I, Wang, X, Babineau, D, Yeo, K.T, Anderson, T, Kimmel, R.J, Angov, E, Lanar, D.E, Narum, D, Dutta, S, Richards, J, Beeson, J.G, Crabb, B.S, Cowman, A.F, Horii, T, Muchiri, E, Mungai, P.L, King, C.L, Kazura, J.W (2016). Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth Cohort. Clinical and Vaccine Immunology 23 (2) : 104-116. ScholarBank@NUS Repository. https://doi.org/10.1128/CVI.00452-15
dc.identifier.issn15566811
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/181392
dc.description.abstractIgG antibodies to Plasmodium falciparum are transferred from the maternal to fetal circulation during pregnancy, wane after birth, and are subsequently acquired in response to natural infection. We examined the dynamics of malaria antibody responses of 84 Kenyan infants from birth to 36 months of age by (i) serology, (ii) variant surface antigen (VSA) assay, (iii) growth inhibitory activity (GIA), and (iv) invasion inhibition assays (IIA) specific for merozoite surface protein 1 (MSP1) and sialic acid-dependent invasion pathway. Maternal antibodies in each of these four categories were detected in cord blood and decreased to their lowest level by approximately 6 months of age. Serologic antibodies to 3 preerythrocytic and 10 blood-stage antigens subsequently increased, reaching peak prevalence by 36 months. In contrast, antibodies measured by VSA, GIA, and IIA remained low even up to 36 months. Infants sensitized to P. falciparum in utero, defined by cord blood lymphocyte recall responses to malaria antigens, acquired antimalarial antibodies at the same rate as those who were not sensitized in utero, indicating that fetal exposure to malaria antigens did not affect subsequent infant antimalarial responses. Infants with detectable serologic antibodies at 12 months of age had an increased risk of P. falciparum infection during the subsequent 24 months. We conclude that serologic measures of antimalarial antibodies in children 36 months of age or younger represent biomarkers of malaria exposure rather than protection and that functional antibodies develop after 36 months of age in this population. Copyright © 2016 American Society for Microbiology. All Rights Reserved.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectbiological marker
dc.subjectimmunoglobulin G
dc.subjectimmunoglobulin M
dc.subjectmerozoite surface protein 1
dc.subjectparasite antigen
dc.subjectprotozoal protein
dc.subjectprotozoon antibody
dc.subjectage
dc.subjectblood
dc.subjectfemale
dc.subjectfetus blood
dc.subjectgrowth, development and aging
dc.subjecthuman
dc.subjectimmunology
dc.subjectinfant
dc.subjectKenya
dc.subjectMalaria, Falciparum
dc.subjectmale
dc.subjectnewborn
dc.subjectpassive immunization
dc.subjectPlasmodium falciparum
dc.subjectpregnancy
dc.subjectPregnancy Complications, Parasitic
dc.subjectpreschool child
dc.subjectserology
dc.subjectAge Factors
dc.subjectAntibodies, Protozoan
dc.subjectAntigens, Protozoan
dc.subjectBiomarkers
dc.subjectChild, Preschool
dc.subjectFemale
dc.subjectFetal Blood
dc.subjectHumans
dc.subjectImmunity, Maternally-Acquired
dc.subjectImmunoglobulin G
dc.subjectImmunoglobulin M
dc.subjectInfant
dc.subjectInfant, Newborn
dc.subjectKenya
dc.subjectMalaria, Falciparum
dc.subjectMale
dc.subjectMerozoite Surface Protein 1
dc.subjectPlasmodium falciparum
dc.subjectPregnancy
dc.subjectPregnancy Complications, Parasitic
dc.subjectProtozoan Proteins
dc.subjectSerologic Tests
dc.typeArticle
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.1128/CVI.00452-15
dc.description.sourcetitleClinical and Vaccine Immunology
dc.description.volume23
dc.description.issue2
dc.description.page104-116
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1128_CVI_00452-15.pdf1.13 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons